BSc (Hons) Biology
The University of Manchester

PhD Molecular and Cell Biology
The University of Glasgow

Ben is a PhD molecular and cell biologist who has experience both within the pharmaceutical industry and within the publishing industry that serves it. He joined Random42 in 2010, first as the Medical Director, before moving into the position of CEO in 2014. Prior to his time at Random42, he was a medical writer, as well as a research scientist for AstraZeneca and The University of Glasgow.